Picture of LENSAR logo

LNSR LENSAR News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Brief: LENSAR Reports Fourth Quarter And Full Year 2020 Results, Provides Update

March 10 (Reuters) - LENSAR Inc  LNSR.O :
    * LENSAR REPORTS FOURTH QUARTER AND FULL YEAR 2020 FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
    * Q4 LOSS PER SHARE $0.78
    * Q4 REVENUE FELL 2.1 PERCENT TO $8.3 MILLION
    * LENSAR - REMAIN ON TRACK TO SUBMIT AN APPLICATION FOR
510(K)
CLEARANCE TO U.S. FDA BY END OF Q1 OF 2022, & IF CLEARED,
COMMERCIAL LAUNCH LATER IN 2022
    * AS OF DEC 31, 2020, CO HAD CASH, EQUIVALENTS OF $40.6
MILLION
    * BELIEVES IT HAS SUFFICIENT CASH TO FUND OPERATIONS THROUGH
FILING OF ITS 510(K) APPLICATION AND EXPECTED LAUNCH OF ALLY IN
2022
    * EXPECTS RESEARCH AND DEVELOPMENT EXPENSES TO CONTINUE TO
INCREASE AS IT NEARS THE 510(K) FILING FOR ALLY

Source text for Eikon:  ID:nBw9jkZwsa 
Further company coverage:  LNSR.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on LENSAR

See all news